Uncertainties in the classification of human cationic trypsinogen (PRSS1) variants as hereditary pancreatitis-associated mutations

Journal of Medical Genetics

Volumn 47, Issue 5, 2010, Pages 348-350

  Szmola, Richárd ^a   Sahin Tóth, Miklós ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; TRYPSINOGEN;

ARTICLE; CHRONIC PANCREATITIS; CLINICAL ARTICLE; DISEASE CLASSIFICATION; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MUTATION; PRIORITY JOURNAL; PRSS1 GENE;

AMINO ACID SUBSTITUTION; FEMALE; GENES, DOMINANT; GENETIC VARIATION; HUMANS; MALE; MUTATION; PANCREATITIS, CHRONIC; PEDIGREE; RECOMBINANT PROTEINS; TRYPSIN;

EID: 77953699769     PISSN: 00222593     EISSN: 14686244     Source Type: Journal    
DOI: 10.1136/jmg.2009.072751     Document Type: Article

References (20)

1. Whitcomb DC, Gorry MC, Preston RA, Furey W, Sossenheimer MJ, Ulrich CD, Martin SP, Gates LK Jr, Amann ST, Toskes PP, Liddle R, McGrath K, Uomo G, Post JC, Ehrlich GD. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996;14:141-5.
2. Teich N, Rosendahl J, Tóth M, Mössner J, Sahin-Tóth M. Mutations of human cationic trypsinogen (PRSS1) and chronic pancreatitis. Hum Mutat 2006;27:721-730.
3. Applebaum-Shapiro SE, Finch R, Pfützer RH, Hepp LA, Gates L, Amann S, Martin S, Ulrich CD, Whitcomb DC. Hereditary pancreatitis in North America: the Pittsburgh-Midwest Multi-Center Pancreatic Study Group Study. Pancreatology 2001;1:439-43.
4. Keim V, Witt H, Bauer N, Bodeker H, Rosendahl J, Teich N, Mössner J. The course of genetically determined chronic pancreatitis. JOP 2003;4:146-54. (Pubitemid 38963782)
5. Howes N, Lerch MM, Greenhalf W, Stocken DD, Ellis I, Simon P, Truninger K, Ammann R, Cavallini G, Charnley RM, Uomo G, Delhaye M, Spicak J, Drumm B, Jansen J, Mountford R, Whitcomb DC, Neoptolemos JP. European Registry of Hereditary Pancreatitis and Pancreatic Cancer (EUROPAC). Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol 2004;2:252-61.
6. Rebours V, Boutron-Ruault MC, Schnee M, Férec C, Le Maréchal C, Hentic O, Maire F, Hammel P, Ruszniewski P, Lévy P. The natural history of hereditary pancreatitis: a national series. Gut 2009;58:97-103.
7. Chen JM, Raguenes O, Férec C, Deprez PH, Verellen-Dumoulin C. A CGC>CAT gene conversion-like event resulting in the R122H mutation in the cationic trypsinogen gene and its implication in the genotyping of pancreatitis. J Med Genet 2000; 37:E36.
8. Howes N, Greenhalf W, Rutherford S, O'Donnell M, Mountford R, Ellis I, Whitcomb D, Imrie C, Drumm B, Neoptolemos JP. A new polymorphism for the R122H mutation in hereditary pancreatitis. Gut 2001;48:247-50.
9. Teich N, Nemoda Z, Kohler H, Heinritz W, Mössner J, Keim V, Sahin-Tóth M. Gene conversion between functional trypsinogen genes PRSS1 and PRSS2 associated with chronic pancreatitis in a six-year-old girl. Hum Mutat 2005;25:343-7.
10. Masson E, Le Maréchal C, Delcenserie R, Chen JM, Férec C. Hereditary pancreatitis caused by a double gain-of-function trypsinogen mutation. Hum Genet 2008;123:521-9.
11. Sahin-Tóth M. Biochemical models of hereditary pancreatitis. Endocrinol Metab Clin North Am 2006;35:303-12.
12. Szmola R, Sahin-Tóth M. Chymotrypsin C (caldecrin) promotes degradation of human cationic trypsin: Identity with Rinderknecht's enzyme Y. Proc Natl Acad Sci U S A 2007;104:11227-32.
13. Nemoda Z, Sahin-Tóth M. Chymotrypsin C (caldecrin) stimulates autoactivation of human cationic trypsinogen. J Biol Chem 2006;281:11879-86.
14. Teich N, Le Marechal C, Kukor Z, Caca K, Witzigmann H, Chen JM, Tóth M, Mossner J, Keim V, Ferec C, Sahin-Tóth M. Interaction between trypsinogen isoforms in genetically determined pancreatitis: mutation E79K in cationic trypsin (PRSS1) causes increased transactivation of anionic trypsinogen (PRSS2). Hum Mutat 2004;23:22-31.
15. Kereszturi E, Szmola R, Kukor Z, Simon P, Weiss FU, Lerch MM, Sahin-Tóth M. Hereditary pancreatitis caused by mutation-induced misfolding of human cationic trypsinogen: a novel disease mechanism. Hum Mutat 2009;30:575-82.
16. Simon P, Weiss FU, Sahin-Tóth M, Parry M, Nayler O, Lenfers B, Schnekenburger J, Mayerle J, Domschke W, Lerch MM. Hereditary pancreatitis caused by a novel PRSS1 mutation (Arg122/Cys) that alters autoactivation and autodegradation of cationic trypsinogen. J Biol Chem 2002;277:5404-10.
17. Chen JM, Kukor Z, Le Maréchal C, Tóth M, Tsakiris L, Raguénès O, Férec C, Sahin-Tóth M. Evolution of trypsinogen activation peptides. Mol Biol Evol 2003;20:1767-77.
18. Sahin-Tóth M. Human cationic trypsinogen. Role of Asn-21 in zymogen activation and implications in hereditary pancreatitis. J Biol Chem 2000;275:22750-5.
19. Liu QC, Gao F, Ou QS, Zhuang ZH, Lin SR, Yang B, Cheng ZJ. Novel mutation and polymorphism of PRSS1 gene in the Chinese patients with hereditary pancreatitis and chronic pancreatitis. Chin Med J (Engl) 2008;121:108-11.
20. Felderbauer P, Schnekenburger J, Lebert R, Bulut K, Parry M, Meister T, Schick V, Schmitz F, Domschke W, Schmidt WE. A novel A121T mutation in human cationic trypsinogen associated with hereditary pancreatitis: functional data indicating a loss-of-function mutation influencing the R122 trypsin cleavage site. J Med Genet 2008;45:507-12.